[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"self-management\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:self-management":69},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,18,0,[8,53,88,114,139,164,192,219,248,276,307,334,364,392,420,446,475,508],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":33,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":52},"100644489","think-find-solve-activities-for-insulin-self-management-in-type-1-diabetes-100644489",false,"NCT07670572","Think-Find-Solve Activities for Insulin Self-Management in Type 1 Diabetes","The Effect of Think-Find-Solve Activities on Insulin Self-Management in Children With Type 1 Diabetes: A Randomized Controlled Trial","Inclusion Criteria:\n\n* For the child:\n\nDiagnosed with Type 1 diabetes Aged between 8 and 12 years Able to read and write Able to understand and speak Turkish Diagnosed with diabetes for at least one year Regularly attending routine three-month outpatient clinic follow-ups Having no other diseases or medical conditions aside from diabetes The child agrees to participate in the study\n\n-For the Parent: Being the mother or father of the child with Type 1 diabetes Being the primary caregiver responsible for the child Able to read and write Agrees to participate in the study\n\nExclusion Criteria:\n\nThe child uses an insulin pump\n\n\\-","ALL","8 Years","12 Years",{"count":20,"type":21},40,"ESTIMATED","INTERVENTIONAL",[24],"NA","Children with type 1 diabetes require lifelong insulin therapy. However, improper management of insulin therapy may lead to serious, potentially life-threatening complications. The aim of this study is to examine the effect of an activity book developed for insulin therapy on insulin self-management among children with type 1 diabetes and their parents. The study is designed as a cluster randomized controlled experimental trial at the center level, including pre-test, 1- month, and 3-month follow-up measurements. The study will be initiated after obtaining ethical approval and institutional permissions. The sample will consist of children aged 8-12 years with type 1 diabetes and their parents. The study will be conducted in two different hospitals in Istanbul; using cluster randomization, one hospital will be assigned to the intervention group and the other to the control group. Prior to the main study, a pilot study will be conducted with 15 participants in each group, and the sample size will be calculated using G\\*Power based on the pilot data. Data will be collected using the \"Descriptive Information Form for Children with Diabetes\" and the \"Insulin Treatment Self-Management Scale (ITSMS) - Child (8-18 years) and Parent Forms.\" The \"Find-Solve-Learn Insulin Self-Management Activity Book\" will be applied to the children in the intervention group. The children will be monitored to complete the activity book at least twice a month for three months, and feedback will be obtained from their families regarding the process. The data collection process will include pre-test, 1-month, and 3-month follow-up measurements. The obtained data will be analyzed using appropriate statistical methods.",[27,28,29,30,31,32],"Type 1 Diabetes","Children","Activity","Insulin","Self Management","Parent",[34,35,36,37,38,39],"type 1 diabetes","children","activity","insulin","self management","parent","NOT_YET_RECRUITING","2026-06-25",{"date":43,"type":44},"2026-06-26","ACTUAL",{"date":46,"type":21},"2026-07-15",{"date":48,"type":21},"2027-06-15",{"name":50,"class":51},"Marmara University","OTHER",1,{"id":54,"slug":55,"hasResults":11,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":11,"sex":16,"minAge":61,"maxAge":4,"enrollmentInfo":62,"targetDuration":4,"studyType":22,"phases":64,"briefSummary":65,"conditions":66,"keywords":70,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":52},"100643324","structured-nursing-intervention-for-adults-with-poorly-controlled-asthma-a-pilot-study-100643324","NCT07635537","Structured Nursing Intervention for Adults With Poorly Controlled Asthma: A Pilot Study","Design and Development of RESPiraIA-Asthma: A Structured Nursing Intervention for the Follow-up of Adults With Poorly Controlled Asthma. A Pilot Study","RESPiraIA-Asma","Inclusion Criteria:\n\n* Confirmed diagnosis of mild or moderate persistent, non-severe asthma.\n* Poorly controlled asthma, defined as an Asthma Control Test (ACT) score below 20.\n* Active inhaled maintenance therapy with inhaled corticosteroids (ICS), alone or combined with a long-acting beta-agonist (LABA).\n* Age 18 years or older.\n* Active follow-up in the Pulmonology outpatient clinic of Hospital Clínico San Carlos.\n* Sufficient cognitive capacity to participate and complete the questionnaires.\n* Access to a means of communication (in-person, telephone, digital, or mixed).\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Significant respiratory comorbidity (chronic obstructive pulmonary disease ( COPD), bronchiectasis, pulmonary fibrosis, chronic pulmonary thromboembolism, or home oxygen therapy).\n* Acute asthma exacerbation within the 4 weeks before inclusion.\n* Participation in another clinical trial within the previous 12 months.\n* Cognitive impairment or language barriers preventing completion of the questionnaires.\n* Conditions limiting continuity of follow-up over the 12 months.\n* Mild comorbidities such as allergic rhinitis or mild sleep apnea are not exclusion criteria.","18 Years",{"count":63,"type":21},30,[24],"Asthma affects a large number of adults, and many of them do not achieve good control of their symptoms. Poor inhaler technique, irregular medication use, and the lack of structured nursing follow-up are among the main reasons. RESPiraIA-Asma is a 12-month structured nursing intervention designed to address these gaps in adults with poorly controlled, non-severe asthma.\n\nThis is a quasi-experimental, single-group, before-and-after pilot study. Each participant is followed across six visits over one year, at baseline and at months 1, 3, 6, 9, and 12. The intervention combines therapeutic education, inhaler technique training, home peak-flow self-monitoring, biopsychosocial assessment, and a standardized nursing care plan based on internationally recognized nursing taxonomies for diagnoses, interventions, and outcomes: NANDA International (NANDA-I), Nursing Interventions Classification (NIC), and Nursing Outcomes Classification (NOC), activated by objective clinical thresholds.\n\nA central principle of the model is digital equity: the same standard of care is offered through three equivalent access routes (digital, mixed, or in-person), chosen according to each participant's digital skills, resources, and preferences, so that technology never becomes a barrier to access.\n\nThe study evaluates whether the model is feasible to deliver in routine clinical practice, measured through participant retention, data completeness, and acceptability, and it looks for preliminary signals of its effect on asthma control, treatment adherence, lung function, and biopsychosocial well-being. As an exploratory pilot, it is not designed to confirm efficacy; its purpose is to inform the design of a larger future trial.",[67,68,69],"Asthma","Medication Adherence","Self-management",[67,71,72,73,74,75,76,77,78],"Nursing Diagnosis","Treatment Adherence and Compliance","Nursing Care","Digital Divide","Digital Technology","Artificial Intelligence","Structured nursing intervention","NANDA-I, NIC, NOC","2026-06-03",{"date":81,"type":44},"2026-06-09",{"date":83,"type":21},"2026-10",{"date":85,"type":21},"2029-09",{"name":87,"class":51},"Hospital San Carlos, Madrid",{"id":89,"slug":90,"hasResults":11,"nctId":91,"briefTitle":92,"officialTitle":93,"acronym":94,"eligibilityCriteria":95,"healthyVolunteers":96,"sex":16,"minAge":61,"maxAge":4,"enrollmentInfo":97,"targetDuration":4,"studyType":22,"phases":99,"briefSummary":100,"conditions":101,"keywords":4,"overallStatus":104,"whyStopped":4,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":108,"completionDateStruct":109,"leadSponsor":111,"locationsCount":113},"100621624","heart-failure-carer-support-programme-implementation-testing-in-the-uk-100621624","NCT07373041","Heart Failure Carer Support Programme: Implementation Testing in the UK.","Implementation Testing of the Heart Failure Carer Support Programme in the United Kingdom.","HELP","Carers\n\nInclusion Criteria\n\n1. Aged 18 years or older\n2. Physical and mental ability to operate a digital device, engage comfortably in conversation with peers, and be able to read written materials\n3. Caring (regular, unpaid care) for a person with a clinical diagnosis of heart failure (HF) who is receiving standard evidence-based HF therapies and has either HF symptoms or 1 episode of decompensation (symptoms requiring medical attention) in previous 6 months\n4. Ability to speak and understand English\n\nExclusion criteria\n\n1. Lacking capacity to give consent\n2. Under the age of 18\n\nPatients\n\nInclusion Criteria\n\n1. Aged 18 years or older\n2. Physical and mental ability to engage comfortably in conversation and be able to read written materials\n3. Clinical diagnosis of HF and receiving standard evidence-based HF therapies and has either HF symptoms or 1 episode of decompensation (symptoms requiring medical attention) in previous 6 months\n4. Ability to speak and understand English\n5. Receiving regular, unpaid support with managing his \u002F her condition from a loved one or friend (e.g., a relative or spouse)\n\nExclusion criteria\n\n1. Lacking capacity to give consent\n2. Under the age of 18\n3. Carer refused to participate in HELP",true,{"count":98,"type":21},360,[24],"Background:\n\nHeart failure (HF) is widespread in the United Kingdom (UK). Many of these patients rely on support from family carers who are ill-prepared and supported for this role. These carers often experience poor mental and physical health because of their caring role. HEart faiLure carer support Programme (HELP) is the first intervention in the UK developed with carers of patients with HF to support them with looking after themselves and the patients they care for.\n\nAim:\n\nTo identify the best way of delivering HELP to all carers across the UK and evaluate its impact on carers and patients.\n\nMethods:\n\nHF Nurses will deliver HELP across 3 sites in the UK to approximately 180 carers of patients with HF. The carers targeted will be those who require additional support (caring for a patient who has HF symptoms). These carers will be nominated for the project by patients identified by nurses at in- and out-patient HF appointments. These patients (around 180) will also be invited to provide information for the project. HELP includes 6 online educational support sessions (1 hour each) delivered weekly, along with an educational booklet and website that provide additional support and advice. We will evaluate the impact of HELP on outcomes for patients (i.e., hospital admissions, GP visits, and quality of life) and carers (i.e., burden, preparedness, and quality of life). Interviews and logs \u002F questionnaires will be completed by participants and staff, which will help us understand how best to deliver HELP. Information for the project will be collected at baseline, during HELP, immediately post-HELP (6 weeks), and 6 months after finishing HELP.\n\nImpact:\n\nThe findings will allow us to develop a plan for giving HELP to all carers throughout the UK to provide them with the education and support they need.",[102,103,31],"Heart Failure","Care Givers","RECRUITING","2026-05-29",{"date":107,"type":44},"2026-06-02",{"date":105,"type":44},{"date":110,"type":21},"2027-11-29",{"name":112,"class":51},"Queen's University, Belfast",5,{"id":115,"slug":116,"hasResults":11,"nctId":117,"briefTitle":118,"officialTitle":118,"acronym":4,"eligibilityCriteria":119,"healthyVolunteers":11,"sex":16,"minAge":61,"maxAge":4,"enrollmentInfo":120,"targetDuration":4,"studyType":22,"phases":121,"briefSummary":122,"conditions":123,"keywords":125,"overallStatus":104,"whyStopped":4,"lastUpdateSubmitDate":130,"lastUpdatePostDateStruct":131,"startDateStruct":133,"completionDateStruct":135,"leadSponsor":137,"locationsCount":52},"100638378","the-development-of-the-walsh-asthma-self-management-programme-and-feasibility-of-implementation-in-adults-with-asthma-in-primary-care-100638378","NCT07609134","The Development of the Walsh Asthma Self-management Programme and Feasibility of Implementation in Adults With Asthma in Primary Care","Inclusion Criteria:\n\n* Adults over 18 years old\n* Adults who meet one of the following criteria:\n\na physician's diagnosis of asthma; coded as asthma (R96) as per the international classification of primary care (ICPC) or international classification of diseases (ICD) code J45 with associated use of asthma medications for 6 months prior to study enrolment.\n\nExclusion Criteria:\n\n* Adults under 18 years old\n* Adults with no diagnosis of asthma\n* Adults receiving asthma education in a specialist hospital or community setting\n* Adults unable to give informed consent\n* Smoking ≥ 10 Pack Year History",{"count":20,"type":21},[24],"Asthma is a common medical condition in Ireland. Adult patients tend to have periods when their asthma is stable and periods when it worsens. In order to reduce these periods of worsening asthma, effective ongoing management is required day to day by adults with asthma. Teaching adults how to manage their asthma effectively, plays a huge role in improving their asthma and having a better overall quality of life. This education on managing asthma has many different parts to it. Most adults will discover they have asthma through their general practitioner (GP) and it will be continued to be checked and managed through their GP or general practice nurse (GPN) in their primary care clinic for the duration of their lives.\n\nThis research study is taking place to find out if a new education programme, will help adults manage their asthma better and improve the symptoms of asthma, reducing its overall impact on day-to-day life. This study is also looking at how easy it is to introduce and for nurses to deliver this study within a GP\u002F primary care centre. This study is to find out if this education programme works in a real life setting and if it can lead to better control of asthma for adults.",[67,69,124],"Asthma Control",[67,126,127,128,129],"self-management education","asthma control","primary care","nursing","2026-05-19",{"date":132,"type":44},"2026-05-27",{"date":134,"type":21},"2026-05",{"date":136,"type":21},"2027-01",{"name":138,"class":51},"Royal College of Surgeons, Ireland",{"id":140,"slug":141,"hasResults":11,"nctId":142,"briefTitle":143,"officialTitle":144,"acronym":145,"eligibilityCriteria":146,"healthyVolunteers":11,"sex":147,"minAge":148,"maxAge":4,"enrollmentInfo":149,"targetDuration":4,"studyType":151,"phases":4,"briefSummary":152,"conditions":153,"keywords":4,"overallStatus":104,"whyStopped":4,"lastUpdateSubmitDate":155,"lastUpdatePostDateStruct":156,"startDateStruct":158,"completionDateStruct":160,"leadSponsor":162,"locationsCount":52},"100638710","endometriosis-self-management-strategies-100638710","NCT07591441","Endometriosis Self-Management Strategies","Endometriosis Self-Management Strategies: Exploring Empowerment and Abandonment Through Lived Experiences","EUmetriosis","Inclusion Criteria:\n\n* living in a European country\n* 16 years or older\n* having been diagnosed with endometriosis or very likely to have endometriosis based on a previous assessment, even if not having received a definitive surgical diagnosis\n* fluent in a language spoken by the research team\n\nExclusion Criteria:\n\n* not meeting one of the inclusion criteria","FEMALE","16 Years",{"count":150,"type":21},150,"OBSERVATIONAL","The goal of this observational study is to document the lived experiences of self-managing endometriosis in people living with endometriosis who live in Europe. The main question it aims to answer is: \\[How\\] do support structures across personal, community, healthcare, and institutional levels influence individuals' experiences of empowerment and abandonment in self-managing endometriosis?\n\nParticipants will describe the everyday actions they take to live with endometriosis, through diary studies, interviews, and focus groups.",[154,69],"Endometriosis","2026-05-12",{"date":157,"type":44},"2026-05-15",{"date":159,"type":44},"2026-01-19",{"date":161,"type":21},"2029-12-31",{"name":163,"class":51},"Wageningen University and Research",{"id":165,"slug":166,"hasResults":11,"nctId":167,"briefTitle":168,"officialTitle":169,"acronym":4,"eligibilityCriteria":170,"healthyVolunteers":11,"sex":16,"minAge":171,"maxAge":4,"enrollmentInfo":172,"targetDuration":4,"studyType":22,"phases":174,"briefSummary":175,"conditions":176,"keywords":181,"overallStatus":104,"whyStopped":4,"lastUpdateSubmitDate":183,"lastUpdatePostDateStruct":184,"startDateStruct":186,"completionDateStruct":188,"leadSponsor":190,"locationsCount":52},"100461830","optimizing-technology-to-improve-medication-adherence-and-bp-control-optima-bp-100461830","NCT05293756","OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)","OPtimizing Technology to Improve Medication Adherence and Blood Pressure Control","Inclusion Criteria:\n\n1. Self-identify as African American\n2. 50 years of age or older\n3. Diagnosed with hypertension, with a systolic blood pressure≥ 130 mmHg but less than 170 mmHg\n4. Prescribed at least two hypertensive, one of which is a diuretic\u002Fthiazide and or calcium channel blocker antihypertensive medication\n5. Own a smartphone with a data plan, the capability to download the Medisafe app, or view videos\n6. Able to read\u002Funderstand English\n\nExclusion Criteria:\n\n1. Unable to give informed consent or judged to have impaired cognitive ability or severe memory\n2. Currently using a medication management application (app)\n3. Experienced a major CVD event or procedure (e.g., myocardial infarction, stroke, heart surgery) within the past year\n4. Patients with a diagnosis of chronic kidney disease (defined as estimated glomerular filtration rate (eGFR) \\\u003C 60 ml\u002Fmin\u002F1.73m2) and\u002For receiving dialysis.","50 Years",{"count":173,"type":21},208,[24],"Hypertension (HTN) has a greater impact on African Americans (AA) than any other U.S. racial group. Uncontrolled blood pressure (BP) contributes to higher rates of disability, death, and health resource use among AA. HTN is the single most influential risk factor for cardiovascular disease (CVD), as well as a risk factor for the incidence of stroke, diabetes, chronic kidney disease, and dementia. Importantly, older adults account for 15% of the U.S. population, and two-thirds of older adults over age 60 have HTN, with higher rates observed in AA older adults. Strategies to support self-managing HTN and BP control are crucial as the older population is projected to age considerably and become more racially and ethnically diverse. Research has documented the negative effects on health and health outcomes of poorly controlled BP and is one of the most important modifiable CVD risk factors. Lower BP targets will require aggressive management and an increase in antihypertensive medications. Therefore, to achieve lower targets in this population, greater efforts, including patient-centered methods will be needed to support self-managing HTN, especially in terms of medication adherence.\n\nAs we shifted into the digital age, the use of mHealth technologies (smart phones, applications, SMS or text messaging) has been a powerful approach and mechanism for the treatment and management of chronic diseases. However, behavioral interventions that incorporate technology do not reach minorities or disadvantaged AA older adults with HTN. OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP) will leverage existing knowledge of effective technology-based components for HTN self-management to support and improve BP control using unique aspects of mHealth platforms in AA older adults. Findings from this study, if confirmed, will improve BP control and support self-managing HTN, as well as has the potential to close the health disparity gap between AA and non-AA older adults with HTN.",[177,178,179,180],"Hypertension","Self-Management","Technology","Quality of Life",[177,178,182],"Home Blood Pressure Monitoring","2026-03-30",{"date":185,"type":44},"2026-04-03",{"date":187,"type":44},"2021-02-14",{"date":189,"type":21},"2027-05-31",{"name":191,"class":51},"Case Western Reserve University",{"id":193,"slug":194,"hasResults":11,"nctId":195,"briefTitle":196,"officialTitle":197,"acronym":4,"eligibilityCriteria":198,"healthyVolunteers":96,"sex":16,"minAge":199,"maxAge":4,"enrollmentInfo":200,"targetDuration":4,"studyType":22,"phases":202,"briefSummary":203,"conditions":204,"keywords":4,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":210,"lastUpdatePostDateStruct":211,"startDateStruct":213,"completionDateStruct":215,"leadSponsor":217,"locationsCount":4},"100631106","dyadic-management-intervention-in-older-people-with-co-occurring-cognitive-impairment-and-diabetes-as-a-supplementary-approach-to-chronic-diseases-self-management-program-100631106","NCT07496359","Dyadic Management Intervention in Older People With Co-occurring Cognitive Impairment and Diabetes as a Supplementary Approach to Chronic Diseases Self-Management Program","Dyadic Management Intervention in Older People With Co-occurring Cognitive Impairment and Diabetes as a Supplementary Approach to Chronic Diseases Self-Management Program: A Hybrid Effectiveness-implementation Study","Inclusion Criteria:\n\n* Individuals with DM aged \\>= 55 years old;\n* Recent glycosylated haemoglobin (HbA1c) level of 6.5% or above without change in diabetes medication within the last 3 months based on centre's records;\n* Subjective cognitive decline (using SCDQ21) (separately reported by the patient and\u002For caregiver) and confirmed by MOCA (Chinese version) screened by the research nurses;\n* Subjects with nominated primary caregivers will be recruited in the intervention group;\n* For caregivers: they will be considered in the project if they have been the primary caregiver for the person for at least 1 year and are providing or involved in the patient's care on a daily basis.\n\nExclusion Criteria:\n\n* Medical diagnoses of dementia;\n* Those who have terminal illness;\n* For caregivers: those who are temporary caregivers and have only provided\u002Finvolved in care for less than a year.","55 Years",{"count":201,"type":21},309,[24],"The goal of this study is to evaluate the effectiveness and implementation of a dyadic management of the Chronic Disease Self-Management Program (CDSMP) for older adults with co-occurring cognitive impairment and diabetes with the involvement of caregivers.\n\nThe main questions it aims to answer are:\n\n* Does the intervention improve diabetes self-management and cognitive function in older adults?\n* How is the implementation of the intervention in real-world settings?\n\nParticipants will:\n\n* Attend weekly CDSMP session over a 6-week period (2.5-hour per session).\n* Provide feedback on their experience with the intervention through interviews and surveys.",[205,206,69,207,208,209],"Choroid Disease","Caregiver","Diabetes","Mild Cognitive Impairment","Older Adults","2026-03-23",{"date":212,"type":44},"2026-03-27",{"date":214,"type":21},"2026-03",{"date":216,"type":21},"2027-12",{"name":218,"class":51},"The Hong Kong Polytechnic University",{"id":220,"slug":221,"hasResults":11,"nctId":222,"briefTitle":223,"officialTitle":224,"acronym":4,"eligibilityCriteria":225,"healthyVolunteers":11,"sex":16,"minAge":61,"maxAge":4,"enrollmentInfo":226,"targetDuration":4,"studyType":22,"phases":228,"briefSummary":229,"conditions":230,"keywords":233,"overallStatus":104,"whyStopped":4,"lastUpdateSubmitDate":239,"lastUpdatePostDateStruct":240,"startDateStruct":242,"completionDateStruct":244,"leadSponsor":246,"locationsCount":52},"100602930","nudge-based-shared-decision-making-and-self-management-in-type-2-diabetes-a-randomized-trial-100602930","NCT07129915","Nudge-Based Shared Decision Making and Self-Management in Type 2 Diabetes: A Randomized Trial","Effect of Nudge-Based Shared Decision Making on Self-Management Among Patients With Type 2 Diabetes: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Confirmed diagnosis of type 2 diabetes\n* Age ≥ 18 years\n* Normal cognitive function (assessed by Mini-Cog score ≥ 3)\n* Basic smartphone operation ability (can independently use WeChat)\n* Willing to participate and sign informed consent\n\nExclusion Criteria:\n\n* Severe acute complications (e.g., ketoacidosis, hyperosmolar coma)\n* Documented cognitive impairment (dementia, Alzheimer's, etc.)\n* Currently participating in other clinical trials\n* Life expectancy \\\u003C 6 months\n* Pregnancy or lactation",{"count":227,"type":21},250,[24],"This study aims to test whether a communication strategy called \"linguistic nudging\" can help doctors and patients with type 2 diabetes make better treatment decisions together, and whether this improves patients' ability to manage their condition.\n\nWhat will happen in the study? - 250 adults with type 2 diabetes from Xiang'an Hospital (Xiamen) will be randomly assigned to one of two groups:\n\nIntervention group:Doctors will receive special training in \"linguistic nudging\" techniques to encourage shared decision-making. Patients will use a mobile app to record medication preferences, and doctors will adjust advice based on these preferences.\n\nControl group:Patients will receive standard diabetes care without these additional strategies.\n\n\\- All participants will be followed for 6 months.\n\nWhat is the study aiming to find out?\n\nThe main goal is to see if patients in the intervention group:\n\nBetter follow medication plans Improve blood sugar monitoring Have better blood sugar control Feel more satisfied with doctor-patient communication\n\nWhy is this important? Good self-management is key to controlling diabetes, but many patients struggle with it. Effective communication during shared decision-making may empower patients to manage their condition day-to-day with greater confidence.\n\nPatient safety and rights:\n\nParticipation is completely voluntary All personal information will be kept strictly confidential Medical support will be provided if any health problems occur during the study Participants may withdraw at any time\n\nThis research has been approved by the Ethics Committee of Xiang'an Hospital (Approval date: October 2025).",[231,232,69],"Diabetes Mellitus, Type 2","Physician-Patient Relations",[234,235,236,237,238],"Linguistic Nudging","Shared Decision Making","Randomized Controlled Trial","Mobile Health Application","Chinese Population","2025-11-23",{"date":241,"type":44},"2025-11-28",{"date":243,"type":44},"2025-11-01",{"date":245,"type":21},"2026-06",{"name":247,"class":51},"Yunxuan Li",{"id":249,"slug":4,"hasResults":11,"nctId":250,"briefTitle":251,"officialTitle":252,"acronym":253,"eligibilityCriteria":254,"healthyVolunteers":11,"sex":16,"minAge":61,"maxAge":4,"enrollmentInfo":255,"targetDuration":4,"studyType":22,"phases":257,"briefSummary":258,"conditions":259,"keywords":262,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":267,"lastUpdatePostDateStruct":268,"startDateStruct":270,"completionDateStruct":272,"leadSponsor":274,"locationsCount":52},"100613103","NCT07262229","Self-management Digital Intervention to Promote Physical Activity in People Living With COPD","Self-management Digital Intervention to Promote Physical Activity in People Living With Chronic Obstructive Pulmonary Disease: a Pilot Randomized Controlled Trial Study Protocol","Respir'airBPCO","Inclusion Criteria:\n\n1. a GOLD COPD diagnosis stage 1 to 4, classification B or E;\n2. admitted electively at Hospital for PR;\n3. had completed the pulmonary rehabilitation program;\n4. age over 18 years;\n5. ability to provide informed consent;\n6. internet access;\n7. ownership of a smartphone or tablet;\n8. self-assessed perceived ease of use of digital devices.\n\nExclusion Criteria:\n\n1. clinical instability confirmed by the team of healthcare professionals;\n2. severe cardiovascular disease confirmed by medical diagnosis;\n3. recent history of neoplasia or autoimmune disease; other physical activity-limiting clinical condition confirmed by medical diagnosis (e.g. neurological disease);\n4. other respiratory disease as primary diagnosis; e) inability to read, understand or speak French;\n\nf) cognitive impairment diagnosed by the medical team.",{"count":256,"type":21},50,[24],"The goal of this pilot randomized controlled trial is to evaluate the feasibility, acceptability, and preliminary effects of a theory-based self-management digital intervention (Respir'air BPCO) designed to promote physical activity in patients with Chronic Obstructive Pulmonary Disease (COPD) after completion of a pulmonary rehabilitation program.\n\nThe main question it aims to answer is:\n\nIs the Respir'air BPCO intervention (mobile app) feasible, acceptable, and preliminarily effective in increasing physical activity, enhancing self-management, improving motivation, and quality of life, while reducing dyspnea severity, exacerbations, and hospitalizations, compared with no additional intervention?\n\nResearchers will compare an experimental group (receiving the Respir'air BPCO intervention + usual care) to a control group (no additional intervention, only usual care)\n\nParticipants will:\n\nBe assigned either to the control group, receiving no additional intervention beyond usual care (traditional pulmonologist follow-up), or to the experimental group, receiving access to the Respir'air BPCO mobile app in addition to usual care.\n\n* Complete baseline assessments immediately after finishing their in-person pulmonary rehabilitation program.\n* Complete follow-up assessments at 3 months and 6 months after the start of the intervention",[260,69,261],"COPD (Chronic Obstructive Pulmonary Disease)","E-health",[263,264,265,266],"self-management","COPD","eHealth","digital intervention","2025-11-21",{"date":269,"type":44},"2025-12-03",{"date":271,"type":21},"2026-01",{"date":273,"type":21},"2026-09",{"name":275,"class":51},"Institut et Haute Ecole de la Santé la Source",{"id":277,"slug":278,"hasResults":11,"nctId":279,"briefTitle":280,"officialTitle":281,"acronym":282,"eligibilityCriteria":283,"healthyVolunteers":11,"sex":16,"minAge":61,"maxAge":284,"enrollmentInfo":285,"targetDuration":4,"studyType":22,"phases":287,"briefSummary":288,"conditions":289,"keywords":292,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":299,"lastUpdatePostDateStruct":300,"startDateStruct":301,"completionDateStruct":303,"leadSponsor":305,"locationsCount":52},"100611476","whatsapp-based-and-family-involved-diabetes-self-management-education-study-100611476","NCT07241078","WhatsApp-Based and Family-Involved Diabetes Self-Management Education Study","The Effect of WhatsApp-Based and Family-Involved Self-Management Education and Support on HbA1c, Family Support, and Self-Management in Individuals With Type 2 Diabetes","WAF-DSMES","Inclusion Criteria: People diagnosed with type 2 diabetes at least six months prior, receiving insulin and\u002For oral antidiabetic therapy, with an HbA1c value of 7% or higher, capable of communicating in Turkish, literate, and possessing the ability to use a smartphone and WhatsApp, as well as having internet access. Participants are required to agree to participate together with a family member who can provide support related to diabetes. Family members involved in the intervention are expected to be able to communicate in Turkish, literate, able to use a smartphone and WhatsApp, have internet access, and reside within reach of the participant with diabetes.\n\n\\-\n\nExclusion Criteria: Individuals will be excluded if they have type 1 diabetes or gestational diabetes, severe cognitive impairment, advanced visual or hearing loss, any condition preventing the use of digital platforms, or communication or language barriers that would hinder participation. Family members will be excluded if they have diabetes, cognitive impairment, advanced visual or hearing loss, inability to use digital tools, or communication and language barriers.\n\n\\-","74 Years",{"count":286,"type":21},88,[24],"The aim of this study is to evaluate the effects of a WhatsApp-based and family-involved self-management education program on self-management, family support, and HbA1c levels among individuals with type 2 diabetes mellitus (T2DM).\n\nHypotheses:\n\n* H1: There will be a significant difference in self-management scores between the intervention group receiving the WhatsApp-based and family-involved self-management education and the control group.\n* H2: There will be a significant difference in HbA1c levels between the intervention group receiving the WhatsApp-based and family-involved self-management education and the control group.\n* H3: There will be a significant difference in family support scores between the intervention group receiving the WhatsApp-based and family-involved self-management education and the control group.\n\nThis randomized controlled trial will be conducted with 44 individuals diagnosed with T2DM who meet the inclusion criteria and one family member per participant (total 88 participants). Eligible patients will be randomly assigned to either the intervention or control group using a computer-generated randomization list.\n\nParticipants (people with diabetes and their family members) in the intervention group will receive a 12-week, WhatsApp-based self-management education program. Educational modules (videos, visuals, and written materials) will be shared separately with each person with diabetes and their participating family member via WhatsApp twice a week. To reinforce learning, a five-question quiz will be sent separately to both the person with diabetes and the family member every Thursday. In addition, a brief follow-up phone call (approximately 10 minutes) will be conducted once a week only with the person with diabetes to review progress and provide feedback. Data collection will occur at baseline and at the end of the 12th week.\n\nParticipants in the control group will continue their routine outpatient follow-ups for three months and complete the same measurement tools at baseline and post-intervention.\n\nData will be collected using the Diabetic Participant Demographic Form, Family Member Demographic Form, Diabetes Self Management Questionnaire, Hensarling's Diabetes Family Support Scale, and the Diabetes Knowledge Scale for Adults. Statistical analyses will be performed using SPSS software. Group comparisons will be analyzed with independent t-tests or Mann-Whitney U tests, and pre-post comparisons with paired t-tests or Wilcoxon tests. A significance level of p\\\u003C0.05 will be used.",[231,290,291,69],"Diabete Mellitus","Diabetes Education",[293,294,295,296,297,38,298],"diabetes","family involved","WhatsApp based","family support","HbA1c","type 2 diabetes","2025-11-16",{"date":267,"type":44},{"date":302,"type":21},"2025-11",{"date":304,"type":21},"2026-11",{"name":306,"class":51},"Koç University",{"id":308,"slug":309,"hasResults":11,"nctId":310,"briefTitle":311,"officialTitle":312,"acronym":4,"eligibilityCriteria":313,"healthyVolunteers":96,"sex":16,"minAge":61,"maxAge":4,"enrollmentInfo":314,"targetDuration":4,"studyType":22,"phases":316,"briefSummary":317,"conditions":318,"keywords":321,"overallStatus":104,"whyStopped":4,"lastUpdateSubmitDate":325,"lastUpdatePostDateStruct":326,"startDateStruct":328,"completionDateStruct":330,"leadSponsor":332,"locationsCount":52},"100579623","the-effect-of-motivational-interviewing-on-diabetes-self-management-and-severity-of-cyberchondria-in-individuals-with-diabetes-100579623","NCT06826703","The Effect of Motivational Interviewing on Diabetes Self-Management and Severity of Cyberchondria in Individuals With Diabetes","the Effect of Motivational Interviewing Based on Health Promotion Model on Diabetes Self-management and Cyberchondria Severity in Individuals With Diabetes","Inclusion Criteria:\n\n* Having diabetes for at least 6 months\n* Being over 18 years old\n* To have sufficient communication skills to answer verbal and written questions and fulfill instructions\n* Being literate\n* No physical, cognitive or mental impairment in answering the questions\n* Willingness to participate in research.\n\nExclusion Criteria:\n\n* Being under 18 years of age\n* Being hospitalized in inpatient treatment institutions due to DM or DM complications during the research process\n* The emergence of any health problem that prevents the person from continuing the research\n* Do not leave the study voluntarily.",{"count":315,"type":21},64,[24],"Objective: The aim of this study was to determine the effects of diabetes education given to individuals with diabetes using motivational interviewing technique based on the health promotion model on diabetes self-management and cyberchondria severity. Materials and Method: The population of the study consisted of 1000 individuals. The sample consisted of 64 individuals, 32 experimental and 32 control, who met the research criteria. The research will be conducted between 15.02.2025-15.03.2025 in Van Regional Training and Research Hospital Diabetes outpatient clinic. Data in the research; Descriptive Information Form, Diabetes Self-Management Scale (DMS), Cyberchondria Severity Scale-Short Form (CSS-SF) scales will be applied. Research experiment Motivational interviewing intervention based on the health belief model will be conducted once a week for 1 month. At the end of 1 month, both scales will be administered again to individuals in both experimental and control groups.",[319,320,69],"Type 2 Diabetes","Motivation",[322,323,263,298,324],"cyberchondria violence","health belief model","motivational interview","2025-04-28",{"date":327,"type":44},"2025-04-30",{"date":329,"type":44},"2025-02-15",{"date":331,"type":21},"2025-08-15",{"name":333,"class":51},"Ataturk University",{"id":335,"slug":336,"hasResults":11,"nctId":337,"briefTitle":338,"officialTitle":339,"acronym":340,"eligibilityCriteria":341,"healthyVolunteers":11,"sex":16,"minAge":61,"maxAge":342,"enrollmentInfo":343,"targetDuration":4,"studyType":22,"phases":345,"briefSummary":346,"conditions":347,"keywords":350,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":355,"lastUpdatePostDateStruct":356,"startDateStruct":358,"completionDateStruct":360,"leadSponsor":362,"locationsCount":4},"100588973","development-and-evaluation-of-a-culturally-sensitive-structured-diabetes-self-management-program-for-people-with-type-2-diabetes-residing-in-qatar-100588973","NCT06948370","Development and Evaluation of a Culturally Sensitive Structured Diabetes Self-Management Program for People With Type 2 Diabetes Residing in Qatar","The PARADIGM-Q Study: Development and Evaluation of a Culturally Sensitive Problem- and AttributesbAsed DIabetes Self-Management Program for People With Type 2 Diabetes Residing in Qatar","PARADIGM-Q","Inclusion Criteria:\n\n1. Adults aged 18 to 65 years.\n2. Diagnosed with Type 2 Diabetes Mellitus.\n3. Most recent HbA1c ≥ 8% (within the last 6 months).\n4. Fluent in Arabic and\u002For English.\n5. Qatari and non-Qatari participants.\n6. Able and willing to attend group-based education sessions.\n\nExclusion Criteria:\n\n1. Diagnosed with any type of diabetes other than Type 2.\n2. Pregnant women.\n3. Presence of major diabetes complications (e.g., renal failure, severe retinopathy, blindness, stroke, heart failure, cancer).\n4. Physical or mental disabilities that would hinder participation in education sessions.\n5. Age below 18 or above 65 years.","65 Years",{"count":344,"type":21},200,[24],"This study is about helping people in Qatar who have Type 2 Diabetes take better care of their health. Diabetes is a common and growing problem in Qatar, and many people need more support and information to manage it well in their daily lives.\n\nRight now, there is a program called DESMOND in Qatar, but it is only available in a few places and can be expensive to run. It also doesn't always work well in the long term. That's why we are creating a new diabetes education program called PARADIGM-Q. This program will be easier to access, more affordable, and designed to match the culture and needs of people living in Qatar.\n\nThe PARADIGM-Q program will teach people how to manage diabetes using real-life examples and group discussions. This method is called Case-Based Learning. It helps people understand their condition better and learn how to make good decisions about food, exercise, medication, and dealing with challenges.\n\nThe project will happen in two main phases:\n\nPhase One: Understanding and Creating the Program\n\nIn the first part, we'll look at different ways of teaching about diabetes and see if a method called Case-Based Learning (CBL) works well. After that, we'll build a curriculum (a plan for teaching) based on the PARADIGM model. This curriculum, called the PARADIGM-Q program, will use the CBL method to teach. We'll also test this new program with a small group of diabetes educators and people with diabetes to make sure it works well. Their feedback will help me make the program even better.\n\nPhase Two: Testing the Program\n\nIn the second part, we'll do a big study using a mix of people from different backgrounds in Qatar who have Type 2 Diabetes. we want to see if the PARADIGM-Q program is better than the program they already have (called DESMOND). we'll look the impact of our new program on different things like how much they know about diabetes, how active they are, their blood sugar levels (HbA1C), and their overall quality of life.\n\nThis study could lead to a new standard for diabetes education in Qatar and other countries in the region, helping more people live healthier lives with diabetes.",[69,348,349],"Type 2 Diabetes Mellitus (T2DM)","Diabetes Self-management",[351,352,353,354],"Type 2 Diabetes Mellitus","Diabetes self-management","Quasi Experimental trial","systematic review and dose response meta-analysis","2025-04-21",{"date":357,"type":44},"2025-04-29",{"date":359,"type":21},"2025-05-20",{"date":361,"type":21},"2027-02-01",{"name":363,"class":51},"Ragae Dughmosh",{"id":365,"slug":366,"hasResults":11,"nctId":367,"briefTitle":368,"officialTitle":369,"acronym":4,"eligibilityCriteria":370,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":371,"targetDuration":4,"studyType":22,"phases":373,"briefSummary":374,"conditions":375,"keywords":378,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":383,"lastUpdatePostDateStruct":384,"startDateStruct":386,"completionDateStruct":388,"leadSponsor":390,"locationsCount":52},"100566047","artificial-intelligence-supported-mobile-application-for-diabetes-self-management-100566047","NCT06650098","Artificial Intelligence-Supported Mobile Application For Diabetes Self-Management","The Effect of Web-Based and Artificial Intelligence-Assisted Personalized Applications on Knowledge Levels Compliance With Treatment and Self-Management Among Diabetic Individuals","Inclusion Criteria:\n\n* Having been diagnosed with diabetes for at least 1 year\n* Being between the ages of 18-65\n* Being open to verbal communication\n* Being able to read and write and speak Turkish\n* Having a smart android phone and being able to use mobile applications\n* Being willing to participate in the study\n\nExclusion Criteria:\n\n* Having a perception disorder and psychiatric disorder that prevents the patient from communicating,\n* Having a condition that prevents them from using a smart phone (advanced retinopathy and neuropathy, internet problems)\n* Being on intensive insulin treatment\n* Having a condition that prevents them from continuing the application phase of the study\n* Wanting to leave the study",{"count":372,"type":21},156,[24],"Patients in the AI-supported mobile application group will be able to log in with a username and password that will be defined specifically for them. Patients will be informed about how the application is used during their first interview. They will enter their personal and disease characteristics (age, gender, height, weight, HbA1C, HDL, LDL) into the application at the entrance. Other sections of the application will include exercise, nutrition, medication tracking, complication tracking and diabetic foot care sections. The person will be asked to enter relevant information in these fields according to their own life and condition (for example; how many times do you use insulin per day, what are your medication times, how do you spend your day in terms of exercise, how many meals do you eat, what is your diet, do you urinate frequently, are you extremely thirsty, are you hungry often, do you have numbness in your hands and feet, etc.). After the patient enters the necessary information, they will also be asked to enter their daily blood sugar measurement values into the system. Thus, the individual\\'s hypo\u002Fhyperglycemia risk, risk analysis, nutrition recommendations, medication reminder system, exercise reminder and incentive warnings will be communicated to the individual thanks to the AI-based mobile application. The aim of this application is to reduce the risk of complications and improve the individual\\'s quality of life by providing personalized recommendations for all the needs of the individual, including alarms and reminders, and to support patients to continue their diabetes education and disease management more actively.",[376,377,69],"Diabetes Mellitus","Artificial Intelligence (AI)",[379,380,263,381,382],"diabetes mellitus","artificial intelligence","level of knowledge","compliance with Treatment","2025-03-24",{"date":385,"type":44},"2025-03-25",{"date":387,"type":21},"2025-04-01",{"date":389,"type":21},"2026-06-01",{"name":391,"class":51},"Uludag University",{"id":393,"slug":394,"hasResults":11,"nctId":395,"briefTitle":396,"officialTitle":397,"acronym":4,"eligibilityCriteria":398,"healthyVolunteers":11,"sex":16,"minAge":61,"maxAge":399,"enrollmentInfo":400,"targetDuration":4,"studyType":22,"phases":402,"briefSummary":403,"conditions":404,"keywords":408,"overallStatus":104,"whyStopped":4,"lastUpdateSubmitDate":411,"lastUpdatePostDateStruct":412,"startDateStruct":414,"completionDateStruct":416,"leadSponsor":418,"locationsCount":52},"100581488","a-digital-health-intervention-to-promote-self-management-in-patients-with-chronic-obstructive-pulmonary-disease-100581488","NCT06850961","A Digital Health Intervention to Promote Self-management in Patients With Chronic Obstructive Pulmonary Disease","A Digital Health Intervention for Promoting Self-management in Patients With Chronic Obstructive Pulmonary Disease - a Feasibility Study","Inclusion Criteria:\n\n* Clinical diagnosis of Chronic Obstructive Pulmonary Disease\n* Mucus-related issues ≥3 times per week\n* Speak and write Norwegian\n* Ability to independently operate a smartphone and\u002For iPad\n\nExclusion Criteria:\n\n* Severe mental illness\n* Substance abuse that hinder participation in the study","90 Years",{"count":401,"type":21},90,[24],"Dyspnea, cough, and chronic mucus hypersecretion are common symptoms in patients with Chronic Obstructive Pulmonary Disease (COPD), which increases risk of infections followed by exacerbations, often leading to hospitalization, disease progression and mortality. This patient group requires lifelong treatment in healthcare. A mobile application was developed to facilitate adherence to evidence-based guidelines for tailored breathing and airway clearance techniques to enhance self-management. The app is only in Norwegian and has a Norwegian name which is \"Pust Deg Bedre\" (PDB). The PDB app is fully developed and tested and can be downloaded for free. The app seems promising as a treatment tool, but has not yet been clinical evaluated. This project aims to 1) explore the feasibility of providing the app for patients with COPD, 2) explore the patients' with COPD experiences with the use of the PDB-app in treating dyspnea and mucus secretion, 3) explore the physiotherapists' experiences with the use of the PDB-app in treating dyspnea and mucus secretion, 4) explore the physiotherapists' experiences with implementing the PDB-app in treatment of patients with COPD, 5) explore the patients' experiences with the education in use of the PDB-app, and 6) At a 6-month follow up: explore the physiotherapists experiences with the usefulness and applicability of PBD-app, and to generally explore their experiences with participating in the project.",[405,69,406,407],"Chronic Obstructive Pulmonary Disease (COPD)","Mobile Application","Feasibility Studies",[264,409,410,69,406],"Digital health intervention","Feasibility","2025-02-24",{"date":413,"type":44},"2025-02-28",{"date":415,"type":44},"2025-01-06",{"date":417,"type":21},"2030-12-31",{"name":419,"class":51},"Western Norway University of Applied Sciences",{"id":421,"slug":422,"hasResults":11,"nctId":423,"briefTitle":424,"officialTitle":425,"acronym":426,"eligibilityCriteria":427,"healthyVolunteers":11,"sex":16,"minAge":61,"maxAge":342,"enrollmentInfo":428,"targetDuration":4,"studyType":22,"phases":430,"briefSummary":431,"conditions":432,"keywords":437,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":438,"lastUpdatePostDateStruct":439,"startDateStruct":441,"completionDateStruct":443,"leadSponsor":444,"locationsCount":52},"100508571","electronic-patient-decision-support-system-for-patients-with-type-2-diabetes-diapadess-100508571","NCT05902156","Electronic Patient Decision Support System for Patients with Type 2 Diabetes (DiaPaDeSS)","The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters","DiaPaDeSS","Inclusion Criteria:\n\n* Patients with type 2 diabetes who had been followed up and treated at the Endocrinology and Metabolic Diseases Polyclinic\n* Aged between 18-65 years\n* Patients who know their diagnosis and can verbally express it\n* Have been diagnosed with type 2 diabetes for at least six months\n* Who are literate\n* Who have internet access at home, who have one of the tools such as a computer, tablet or smartphone and can use these tools\n* Consented to participate in the study\n* Had no other psychiatric or mental barriers to answering the questions, language or cognitive difficulties, and barriers to verbal or written communication\n\nExclusion Criteria:\n\n* Diagnosed with myocardial infarction, stroke or diabetic foot in the last six months\n* Diagnosed with type 1 diabetes or gestational diabetes\n* Diagnosed with terminal illness\n* Using steroid therapy\n* Had pregnant\n* Having dementia and cognitive deficits\n* Having retinopathy or advanced neuropathy\n* Patients whose information is not allowed to be accessed",{"count":429,"type":21},72,[24],"This study evaluates the effects of an electronic patient decision support system developed for the use of patients with type 2 diabetes (DiaPaDeSS) on self-management, patient activation, and metabolic parameters. To manage type 2 diabetes after discharge, patients must continue to perform interventions at home, such as blood glucose monitoring, blood pressure measurement, weight measurement, medication use, and foot care. To achieve this, patient's self-management and activation levels should be increased. This can also lead to positive improvements in the metabolic parameters. It would be beneficial to develop DiaPaDeSS that can increase the self-management and activation levels of patients with type 2 diabetes. The investigators will develop the DiaPaDeSS intervention protocol. Our content includes patient education information about type 2 diabetes, self-management practice tasks (daily, weekly, quarterly), a type 2 diabetes patient education program according to DiaPaDeSS algorithms, and measurement questionnaires. The content of the DiaPaDeSS will be evaluated by 10 experts in the fields of medicine, nursing, and informatics. A feasibility test with seven patients will be conducted to evaluate the usability of DiaPaDeSS. A single-blind, randomized controlled trial design will be used. Patients with type 2 diabetes will be pretested and randomized (intervention 36, control 36) to the DiaPaDeSS intervention and control groups. Both the DiaPaDeSS intervention and control groups will use the DiaPaDeSS for three months. While participants in the DiaPaDeSS intervention group can reach all contents of the DiaPaDeSS, others can reach only these fields: self-management practice tasks (daily, weekly, quarterly), and measurements questionnaires. The effectiveness of the DiaPaDeSS will be evaluated at baseline and at month 3.",[433,319,434,178,435,436,236],"Mobile Health","Patient Activation","Decision Support System","Nursing",[433,319,434,435,178,436,236],"2025-02-04",{"date":440,"type":44},"2025-02-06",{"date":442,"type":21},"2025-03-30",{"date":243,"type":21},{"name":445,"class":51},"Akdeniz University",{"id":447,"slug":448,"hasResults":11,"nctId":449,"briefTitle":450,"officialTitle":451,"acronym":4,"eligibilityCriteria":452,"healthyVolunteers":11,"sex":16,"minAge":18,"maxAge":61,"enrollmentInfo":453,"targetDuration":4,"studyType":22,"phases":455,"briefSummary":456,"conditions":457,"keywords":459,"overallStatus":104,"whyStopped":4,"lastUpdateSubmitDate":466,"lastUpdatePostDateStruct":467,"startDateStruct":469,"completionDateStruct":471,"leadSponsor":473,"locationsCount":52},"100551555","effect-of-health-diary-on-self-management-in-adolescent-patients-with-fixed-orthodontic-appliance-100551555","NCT06461611","Effect of Health Diary on Self-management in Adolescent Patients With Fixed Orthodontic Appliance","Effect of Health Diary on Self-management in Adolescent Patients With Orthodontic Fixed Appliance: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients with malocclusion eligible for fixed appliance orthodontic treatment;\n* The age of patients ranged from 12 to 18 years;\n* The patients received orthodontic treatment for the first time;\n* The patient was alert and had no cognitive or psychiatric impairment;\n* The patient was able to read and fill out the questionnaires, and had good listening, speaking and understanding skills in Chinese.\n\nExclusion Criteria:\n\n* The patient's disease was diagnosed as jaw deformity associated with other diseases. Malocclusion secondary to trauma, tumor, cleft lip and palate;\n* Patients treated with orthodontic-orthognathic surgery;\n* The patient currently participating in other oral related intervention studies.",{"count":454,"type":21},140,[24],"This study aims to use two-arm randomized clinical trials to evaluate the effectiveness of the health diary in helping adolescents wearing fixed orthodontic appliances improve their oral hygiene status, self-management skills, oral health-related quality of life, self-efficacy, intention，number of breakages, and on-time and return visit status.",[458,178],"Oral Hygiene",[460,461,462,178,463,464,465,458],"Malocclusion","Fixed Orthodontic Treatment","Adolescent","Self-Efficacy","Health Diary","Oral Health-Related Quality of Life","2024-07-24",{"date":468,"type":44},"2024-07-25",{"date":470,"type":44},"2024-06-01",{"date":472,"type":21},"2025-07-31",{"name":474,"class":51},"Wei XIA, PhD",{"id":476,"slug":477,"hasResults":11,"nctId":478,"briefTitle":479,"officialTitle":480,"acronym":4,"eligibilityCriteria":481,"healthyVolunteers":11,"sex":16,"minAge":61,"maxAge":4,"enrollmentInfo":482,"targetDuration":4,"studyType":22,"phases":483,"briefSummary":484,"conditions":485,"keywords":491,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":499,"lastUpdatePostDateStruct":500,"startDateStruct":502,"completionDateStruct":504,"leadSponsor":506,"locationsCount":52},"100551808","effects-of-a-health-intervention-on-fear-of-hypoglycemia-100551808","NCT06464900","Effects of a Health Intervention on Fear of Hypoglycemia","Effects of a Health Education Intervention Based on the Behaviour Change Wheel on Fear of Hypoglycemia in Patients With Type 2 Diabetes Mellitus: a Randomized Controlled Study","Inclusion Criteria:\n\n* Comply with the 2020 Chinese guidelines for the prevention and treatment of type 2 diabetes mellitus;\n* Age ≥18 years;\n* Duration of diabetes mellitus ≥1 year;\n* FoH according to the elevated item endorsement criterion (E I criterion): ≥3 points on any item of the Hypoglycemic Fear-Worry Scale (HFS-WS);\n* Patients who have the ability to listen, read, write, walk, and cooperate to complete the study;\n* Patients who have a smart phone, and can skillfully use WeChat or telephone to communicate;\n* Voluntarily participate in this study and sign the informed consent form.\n\nExclusion Criteria:\n\n* Patients with comorbid acute complications or other serious diseases or disorders of consciousness, such as diabetic hypertonic state, tumors, coma, etc;\n* Patients with comorbid psychiatric diseases or taking psychotropic drugs;\n* Patients who have recently or are participating in other studies on similar topics.",{"count":401,"type":21},[24],"To examine the effects of a health Education Intervention based on the Behaviour Change Wheel (BCW) theory on fear of hypoglycemia and relevant outcomes of type 2 diabetic patients.",[486,487,488,489,178,490],"Health-Related Behavior","Health Education","Fear of Hypoglycemia","Impaired Awareness of Hypoglycemia","Type2 Diabetes Mellitus",[492,493,494,495,496,497,498],"Behaviour Change Wheel","Health educational intervention","Fear of hypoglycaemic","Impaired awareness of hypoglycaemia","Medical support","Self-management attitude","Type 2 diabetes mellitus","2024-07-07",{"date":501,"type":44},"2024-07-09",{"date":503,"type":21},"2024-07",{"date":505,"type":21},"2025-01",{"name":507,"class":51},"Yangzhou University",{"id":509,"slug":510,"hasResults":11,"nctId":511,"briefTitle":512,"officialTitle":513,"acronym":514,"eligibilityCriteria":515,"healthyVolunteers":11,"sex":16,"minAge":61,"maxAge":4,"enrollmentInfo":516,"targetDuration":4,"studyType":22,"phases":518,"briefSummary":519,"conditions":520,"keywords":523,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":528,"lastUpdatePostDateStruct":529,"startDateStruct":531,"completionDateStruct":533,"leadSponsor":535,"locationsCount":4},"100548673","mitigating-toxicity-by-electronic-health-portal-mediated-interactive-monitoring-of-patient-reported-side-effects-100548673","NCT06424054","Mitigating Toxicity by Electronic Health Portal-mediated Interactive Monitoring of Patient-reported Side Effects","Mitigating Toxicity of (Neo)Adjuvant Chemotherapy by Applying Electronic Health Portal-mediated Interactive Monitoring of Patient-reported Side Effects: the Prospective Randomized eChemoCoach Trial","eChemoCoach","Inclusion Criteria:\n\n* \\- Starting (neo)adjuvant treatment with chemotherapy for breast cancer according to one of the below mentioned treatment protocols:\n\n  * Four cycles of doxorubicin 60mg\u002Fm2 and cyclophosphamide 600mg\u002Fm2 (AC) dose dense q 2 weeks, followed by twelve cycles of weekly paclitaxel 80mg\u002Fm2 (also in combination with carboplatin AUC6 q 3 weeks)\n  * Nine cycles q 3 weeks of paclitaxel 80mg\u002Fm2 on day 1 and 8, carboplatin AUC 3 on day 1 and 8, trastuzumab 8mg\u002Fkg loading dose (followed by doses of 6mg\u002Fm2 at subsequent cycles) on day1 and pertuzumab loading dose of 840mg (followed by doses of 420mg at subsequent cycles) on day 1\n* Age ≥ 18 years\n* WHO PS ≤1\n* Capable of using the EHP or get help in case of low (e-)health literacy. This includes being capable of login using DigiD, a system used by the Dutch government to verify the identity of a person\n* Being able to read or get help from a relative in case of illiteracy\n\nExclusion Criteria:\n\n* \\- Participation in a trial with an investigational product (because more frequent and structured symptom reporting is performed in these studies).\n* Patients who have been treated with chemotherapy in the past (since these patients are at higher risk for developing side effects of current chemotherapy).\n* Patients that already started with their chemotherapy cycle",{"count":517,"type":21},746,[24],"Chemotherapy induces side effects varying in severity, impacting patients' quality of life and necessitating unplanned hospital care. Patient-reported outcomes (PROs) could aid in early detection and management of side effects. However, existing PRO monitoring lacks triage capabilities, leading to clinician involvement and suboptimal symptom management. The investigators propose eChemoCoach, an electronic questionnaire integrated into the electronic health portal, offering real-time symptom assessment and personalized advice based on CTCAE criteria. Our study aims to assess the impact of eChemoCoach on non-hematological CTCAE ≥ 3 graded side effects in early breast cancer patients undergoing chemotherapy. This is a randomized controlled trial involving 746 patients that will evaluate the eChemoCoach's efficacy compared to standard monitoring. Phase one will validate questionnaires and assess usability, while phase two focuses on the primary outcome. Te investigators anticipate reduced severe side effects, thereby enhancing patients' quality of life, reducing stress, and minimizing hospital visits.",[521,265,522,31],"Breast Cancer","Symptom Monitoring",[521,524,525,265,526,527],"remote monitoring","emonitoring","symptom management","symptom monitoring","2024-05-16",{"date":530,"type":44},"2024-05-21",{"date":532,"type":21},"2025-06-01",{"date":534,"type":21},"2029-12-01",{"name":536,"class":51},"Noordwest Ziekenhuisgroep"]